Clinical Trials Logo

Preterm Children clinical trials

View clinical trials related to Preterm Children.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04945369 Recruiting - Preterm Children Clinical Trials

Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".

INFANTPOD
Start date: February 2, 2022
Phase: N/A
Study type: Interventional

Prematurity is associated with an increased risk of developing cardiovascular and metabolic disturbances in adulthood. It has been demonstrated that the body composition of children born prematurely is different from that of children born under term with a deficit in fat free mass. It can thus be wondered if this excessive adiposity does or does not predict the risk of insulin resistance in adulthood. Children born prematurely, with a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol, and now aged between 8 and 14 years, will be included in the INFANTPOD protocol. Analysis of body composition, insulin resistance, renal function, pulse wave velocity, eating behaviour and of physical activity will be performed.